Neutrolin Versus Heparin for Locking Hemodialysis Catheters
Status:
Unknown status
Trial end date:
2021-04-04
Target enrollment:
Participant gender:
Summary
Hemodialysis catheter related bacterial infections represent a major cause of mortality and
morbidity in the hemodialysis population. Several locking agents had been tried with variable
degree of success but not without side effects.
Neutrolin catheter locking agent comprises of heparin,citrate and trauolidine that had been
studied in a prospective study in Germany, and it demonstrated a very good result in terms of
reducing the catheter related infections and thrombosis.
This study is a multi-center, double-blind RCT comparing the hemodialysis catheter locking
solution Neutrolin with heparin in reducing the rate of catheter related bacterial infection
and thrombosis.
Phase:
N/A
Details
Lead Sponsor:
King Abdullah International Medical Research Center